Director/PDMR Shareholding

RNS Number : 9138W

GlaxoSmithKline PLC

29 April 2016

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) I give details of changes in the notional interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR'), who acquired Ordinary Shares and American Depositary Shares ('ADSs'), at a price of 1502.00 pence per Ordinary Share and $42.64 per ADS, following the re-investment of dividends paid to Shareholders on 14 April 2016, on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	3,883.790	3,883.790
Mr S Dingemans	2,089.773	2,089.773
Mr R G Connor	858.228	858.228
Mr N Hirons	548.422	548.422
Mr S A Hussain	1,556.838	1,556.838
Mr D S Redfern	1,077.470	1,077.470
Ms C Thomas	1,271.298	1,271.298
Mr P C Thomson	460.665	460.665
Dr P J T Vallance	2,084.049	2,084.049
Ms E Walmsley	1,506.621	1,506.621

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	1,543.193	1,543.193
Mr D E Troy	846.539	846.539

GlaxoSmithKline plc ('GSK') was advised of these allocations on 28 April 2016.

V A Whyte

Company Secretary

29 April 2016

 

END

 

 

DSHQKLFLQZFLBBL